Skip to main content
. 2022 May 2;23:108. doi: 10.1186/s12931-022-02036-3

Table 1.

Patient characteristics, matched pairs*, cross-sectional, Non-Bos/BOS

Non-BOS (n = 20) BOS (n = 20)
Diagnosis Age Tx type Gender Diagnosis Age Tx type Gender BOS
A1AT 47 SL M A1AT 53 SL F 3b
A1AT 57 SL F A1AT 51 BL* F 2b
CF 31 BL M CF 25 BL M 3b
CF 35 BL M CF 21 HL* M 3b
COPD 47 SL F COPD 47 SL F 2a
COPD 47 SL F COPD 53 SL F 2b
COPD 53 SL F COPD 47 SL F 3a
COPD 53 SL F COPD 52 SL F 2a
COPD 55 SL F COPD 55 SL F 2b
COPD 64 SL M COPD 56 SL M 3a
Eisenmenger 32 HL M Eisenmenger 16 HL M 3b
Eisenmenger 30 HL M Eisenmenger 35 HL M 3a
Eisenmenger 40 HL F Eisenmenger 51 HL F 3b
HUVS 39 BL F BAC 47 BL F 3a
IPF 54 SL F IPF 51 SL F 2a
PAH 22 HL M PAH 29 BL M 3b
PAH 43 BL F PAH 26 BL F 2b
PAH 40 BL F PAH 33 BL F 3a
PAH 42 HL F PAH 45 HL F 3b
PAH 47 BL M PAH 51 BL M 3a

BOS bronchiolitis obliterans syndrome, A1AT α-1-antitrypsin deficiency, CF cystic fibrosis, COPD chronic obstructive pulmonary disease, HUVS hypocomplementemic urticarial vasculitis syndrome, BAC bronchioloalveolar carcinoma, IPF idiopathic pulmonary fibrosis, PAH pulmonary arterial hypertension, Tx transplantation, SL single-lung, BL bilateral lung, HL heart and bilateral lung, F female, M male

*Matched for pre-transplant diagnosis, age, gender, type of surgery and sampling time after surgery